CDC7 and cancer: In preclinical in-vivo and in-vitro cancer models, CDC7 inhibition by TAK-931 resulted in prolonged replication stress and consequent mitotic aberrations, and proliferation inhibition; furthermore, TAK-931 showed antiproliferative activity in a broad range of cancer cell lines and multiple patient-derived xenograft models [10].